PuSH - Publication Server of Helmholtz Zentrum München

Katsumoto, K.* ; Yennek, S.* ; Chen, C. ; Silva, L.F.D.* ; Traikov, S.* ; Sever, D.* ; Azad, A.* ; Shan, J.* ; Vainio, S.* ; Ninov, N. ; Speier, S. ; Grapin-Botton, A.

Wnt4 is heterogeneously activated in maturing β-cells to control calcium signaling, metabolism and function.

Nat. Commun. 13:6255 (2022)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Diabetes is a multifactorial disorder characterized by loss or dysfunction of pancreatic β-cells. β-cells are heterogeneous, exhibiting different glucose sensing, insulin secretion and gene expression. They communicate with other endocrine cell types via paracrine signals and between β-cells via gap junctions. Here, we identify the importance of signaling between β-cells via the extracellular signal WNT4. We show heterogeneity in Wnt4 expression, most strikingly in the postnatal maturation period, Wnt4-positive cells, being more mature while Wnt4-negative cells are more proliferative. Knock-out in adult β-cells shows that WNT4 controls the activation of calcium signaling in response to a glucose challenge, as well as metabolic pathways converging to lower ATP/ADP ratios, thereby reducing insulin secretion. These results reveal that paracrine signaling between β-cells is important in addition to gap junctions in controling insulin secretion. Together with previous reports of WNT4 up-regulation in obesity our observations suggest an adaptive insulin response coordinating β-cells.
Impact Factor
Scopus SNIP
Altmetric
17.694
3.341
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Quellenangaben Volume: 13, Issue: 1, Pages: , Article Number: 6255 Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502600-005
G-502600-010
Grants Novo Nordisk Fonden (Novo Nordisk Foundation)
Deutsche Forschungsgemeinschaft (German Research Foundation)
Scopus ID 85140338062
PubMed ID 36271049
Erfassungsdatum 2022-10-26